News
CHMP recommends Sanofi’s Xenpozyme for rare disease ASMD
The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion for Sanofi’s Xenpozyme (olipudase alfa).
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion for Sanofi’s Xenpozyme (olipudase alfa).